En niños preescolares | 22 AGO 16

Prevención de exacerbaciones de sibilancias recurrentes

La mitad de los niños experimentan uno o más episodios de sibilancias hasta los 6 años de edad con morbilidad sustancial, carga para el cuidador, y costos de cuidado de la salud
Autor/a: Sunitha V. Kaiser, Tram Huynh, Leonard B. Bacharier, Jennifer L. Rosenthal, Leigh Anne Bakel, Patricia C. Parkin, Michael D. Cabana Preventing Exacerbations in Preschoolers With Recurrent Wheeze: A Meta-analysis
INDICE:  1. Página 1 | 2. Página 1
Página 1

 1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ; The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med. 1995; 332(3):133–138

 2. Laforest L, Yin D, Kocevar VS, et al. Association between asthma control in children and loss of workdays by caregivers. Ann Allergy Asthma Immunol. 2004; 93(3):265–271

 3. American Lung Association. Asthma & children fact sheet. 2014. Available at: www. lung. org/lung- health- and diseases/lung- disease- lookup/ asthma/learn- about- asthma/ asthma- children facts-sheet. html? referrer= https://www. google. com/

 4. Centers for Disease Control and Prevention. National surveillance of asthma. Atlanta, GA: Centers for Disease Control and Prevention; 2012:2001–2010

 5. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007. [Erratum appears in J Allergy

Clin Immunol. 2008; 121(6):1330] J Allergy Clin Immunol. 2007; 120(5 suppl):S94–S138

 6. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009; 123(3). Available at: www. pediatrics. org/cgi/content/ full/123/3/e519

 7. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006; 354(19):1985–1997

 8. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008; 32(4):1096–1110

 9. Bacharier LB, Phillips BR, Bloomberg GR, et al; Childhood Asthma Research and Education Network, National Heart, Lung, and Blood Institute. Severe intermittent wheezing in preschool children: a distinct phenotype. J Allergy Clin Immunol. 2007; 119(3):604–610

 10. Chipps BE, Bacharier LB, Harder JM. Phenotypic expressions of childhood wheezing and asthma: implications for therapy. J Pediatr. 2011; 158:878–84 e1

 11. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Available at: www.ginasthma. org

 12. Sawicki GS, Smith L, Bokhour B, et al. Periodic use of inhaled steroids in children with mild persistent asthma: what are pediatricians recommending? Clin Pediatr (Phila). 2008; 47(5):446–451

 13. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014; 383(9928):1593–1604

 14. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535

 15. Hasegawa K, Tsugawa Y, Brown DF, Camargo CA, Jr. Childhood asthma hospitalizations in the United States, 2000–2009. J Pediatr. 2013; 163:1127–1133 e3

 16. Davies BR, Carroll WD. The use of inhaled corticosteroids in the wheezy under 5-year-old child. Arch Dis Child Educ Pract Ed. 2011; 96(2):61–66

 17. Gionfriddo MR, Hagan JB, Hagan CR, Volcheck GW, Castaneda-Guarderas A, Rank MA. Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysis. Allergy Asthma Proc. 2015; 36(4):262–267

 18. Higgins JPAD, Gøtzsche PC, Jüni P, et al; Cochrane Bias Methods Group. Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928

 19. Bacharier LB, Phillips BR, Zeiger RS, et al; CARE Network. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008; 122(6):1127–1135.e8

 20. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med. 1999; 160(1):126–131

 21. Brand PLP, Luz García-García M, Morison A, Vermeulen JH, Weber HC. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respir Med. 2011; 105(11):1588–1595

 22. Carlsen KCL, Stick S, Kamin W, Cirule I, Hughes S, Wixon C. The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med. 2005; 99(11):1393–1402

 23. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child. 1993; 68(1):85–87

 24. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child. 1993; 69(3):351–355

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024